National HealthCare (NYSE:NHC – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report released on Monday.
National HealthCare Price Performance
Shares of NYSE:NHC traded up $0.21 on Monday, reaching $93.38. The company’s stock had a trading volume of 64,721 shares, compared to its average volume of 58,433. National HealthCare has a 52-week low of $87.03 and a 52-week high of $138.49. The company has a market cap of $1.44 billion, a P/E ratio of 11.70 and a beta of 0.45. The company has a 50-day simple moving average of $100.51 and a 200 day simple moving average of $116.15. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.77 and a current ratio of 1.80.
Insider Buying and Selling
In other news, insider Health Corp National sold 28,147 shares of the stock in a transaction that occurred on Friday, December 20th. The stock was sold at an average price of $113.71, for a total value of $3,200,595.37. Following the sale, the insider now directly owns 1,056,616 shares in the company, valued at approximately $120,147,805.36. This represents a 2.59 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Timothy J. Shelly sold 614 shares of the stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $121.44, for a total value of $74,564.16. The disclosure for this sale can be found here. 13.75% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On National HealthCare
About National HealthCare
National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.
Further Reading
- Five stocks we like better than National HealthCare
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What is the Australian Securities Exchange (ASX)
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Upcoming IPO Stock Lockup Period, Explained
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.